Loading

Please wait...

Menveo

Generic Name: meningococcal conjugate vaccine (me NIN je KOK al KON je gate vax EEN)
Brand Names: Menactra, Menveo
Menveo (meningococcal conjugate vaccine) is used to prevent infection caused by meningococcal bacteria. Includes Menveo side effects, interactions and indications.
  • Prescription Settings
  • X
  • Local Pharmacy Pickup available at . Pick up your medication at any of our participating pharmacies.
  • Mail Order Home Delivery available at , the easiest way to receive your medications.
  • Learn more

Menveo Coupons & Prices

Set your location
for drug prices near you

Enter your zip code

Please wait while the prices are loaded...
Click here to try again.

Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:

Drug Information:
Menveo (meningococcal conjugate vaccine) is used to prevent meningococcal disease, an infection caused by meningococcal bacteria. These bacteria can infect the spinal cord and brain, causing meningitis that can be fatal. Meningococcal disease can also lead to permanent and disabling medical problems. Meningococcal disease can spread from one person to another through small droplets of saliva that are expelled into the air when an infected person coughs or sneezes. The bacteria can also be passed through contact with objects the infected person has touched, such as a door handle or other surface. The bacteria can also be passed through kissing, or sharing a drinking glass or eating utensil with an infected person. Learn more

Buy Menveo online and Menveo delivery

USARx offers multiple ways to purchase this medication. Choose the Best option for you!

  • Guaranteed Price
    Local Pharmacy Pickup

    Pay this amount and pick up your prescription at ANY Retail pharmacy of your choice! Walgreens, CVS, Walmart, etc.

  • 30-day supply
    90-day supply
    Mail Order Home Delivery

    The easiest way to receive your medications.

Menveo Side Effects

Note: This document contains side effect information about meningococcal conjugate vaccine. Some of the dosage forms listed on this page may not apply to the brand name Menveo.

For the Consumer

Applies to meningococcal conjugate vaccine: intramuscular suspension

Along with its needed effects, meningococcal conjugate vaccine (the active ingredient contained in Menveo) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking meningococcal conjugate vaccine:

More common

  • Chills
  • fever
  • general feeling of discomfort or illness
  • unusual tiredness or weakness

Incidence not known

  • Back pain, sudden and severe
  • blurred vision
  • burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
  • confusion
  • cough
  • difficulty with swallowing
  • dizziness
  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
  • fainting
  • fast heartbeat
  • flushing or redness of the skin
  • hives or welts
  • inability to move the arms and legs
  • itching
  • muscle weakness, sudden and progressing
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • seizures
  • shortness of breath
  • skin rash
  • sudden numbness and weakness in the arms and legs
  • sweating
  • tightness in the chest
  • unusually warm skin
  • wheezing

Some side effects of meningococcal conjugate vaccine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • Crying
  • diarrhea
  • difficulty with moving
  • drowsiness
  • irritability
  • loss of appetite
  • muscle pain or stiffness
  • pain in the joints
  • pain, redness, swelling, or tenderness at the injection site
  • vomiting

For Healthcare Professionals

Applies to meningococcal conjugate vaccine: intramuscular powder for injection, intramuscular solution

General

The most common adverse events were injection site pain, irritability, diarrhea, headache, and fatigue.

Local

Very common (10% or more): Injection site pain (48.1%), injection site redness (16%), injection site induration (11%)

Common (1% to 10%): Injection site swelling, injection site hematoma

Uncommon (0.1% to 1%): Injection site pruritus

Postmarketing reports: Injection site reaction, injection site cellulitis, extensive swelling of the injected limb (frequently associated with erythema, sometimes involving the adjacent joint or swelling of the entire injected limb)

Nervous system

Very common (10% or more): Headache (41.8%), drowsiness (11.2%)

Uncommon (0.1% to 1%): Dizziness, hypoesthesia

Postmarketing reports: Vasovagal syncope, paresthesia, Guillain-Barre syndrome, vertigo, tonic convulsion, febrile convulsion, vertigo, vestibular disorder, syncope, facial paresis, balance disorder

Gastrointestinal

Very common (10% or more): Diarrhea (14%), nausea

Common (1% to 10%): Vomiting, gastrointestinal symptoms

Other

Very common (10% or more): Fatigue (32.3%), malaise (22.3%), fever

Common (1% to 10%): Chills, crying

Postmarketing reports: Asthenia, impaired hearing, ear pain, fall, head injury, body temperature increased

Dermatologic

Common (1% to 10%): Rash

Uncommon (0.1% to 1%): Pruritus

Postmarketing reports: Bullous conditions

Musculoskeletal

Very common (10% or more): Arthralgia (16%), myalgia

Uncommon (0.1% to 1%): Pain in extremity

Postmarketing reports: Bone pain

Psychiatric

Very common (10% or more): Irritability (12.2%)

Common (1% to 10%): Insomnia

Metabolic

Very common (10% or more): Appetite lost

Common (1% to 10%): Anorexia, eating disorder

Respiratory

Uncommon (0.1% to 1%): Nasopharyngitis

Postmarketing reports: Oropharyngeal pain

Hypersensitivity

Postmarketing reports: Hypersensitivity (such as rash, urticaria, pruritus, dyspnea, angioedema) including anaphylaxis

Hepatic

Postmarketing reports: Alanine aminotransferase increased

Ocular

Postmarketing reports: Eyelid ptosis

Editorial References and Review

Medically reviewed by USARx EDITORIAL TEAM Last updated on 1/1/2020.

Source: Drugs.com Menveo (www.drugs.com/menveo.html).